tiprankstipranks
Advertisement
Advertisement

EVMN Stock Latest News

Evommune Stockholders Reelect Directors and Ratify Auditor
Company AnnouncementsEvommune Stockholders Reelect Directors and Ratify Auditor
5d ago
8K
EVMN
Evommune Buy Rating Reiterated by Kapoor on EVO756 CSU Catalyst; 12-Month Price Target Maintained at $50
PremiumRatings
Evommune Buy Rating Reiterated by Kapoor on EVO756 CSU Catalyst; 12-Month Price Target Maintained at $50
13d ago
EVMN
Matt Phipps Reiterates Buy on Evommune as EVO301 Data Strengthen IL‑18 Blockade Thesis and Support Blockbuster Potential
PremiumRatings
Matt Phipps Reiterates Buy on Evommune as EVO301 Data Strengthen IL‑18 Blockade Thesis and Support Blockbuster Potential
24d ago
EVMN
Evommune price target raised to $55 from $54 at Morgan Stanley
PremiumThe Fly
Evommune price target raised to $55 from $54 at Morgan Stanley
27d ago
EVMN
Evommune Earns Buy Rating on Late-Stage Pipeline Progress and Multiple Near-Term Clinical Catalysts
PremiumRatings
Evommune Earns Buy Rating on Late-Stage Pipeline Progress and Multiple Near-Term Clinical Catalysts
1M ago
EVMN
Evommune reports Q1 EPS (64c), consensus (71c)
PremiumThe FlyEvommune reports Q1 EPS (64c), consensus (71c)
1M ago
EVMN
Evommune Highlights Q1 Results and Advancing Inflammation Pipeline
Premium
Company Announcements
Evommune Highlights Q1 Results and Advancing Inflammation Pipeline
1M ago
8K
EVMN
Evommune initiated with a Buy at Stifel
Premium
The Fly
Evommune initiated with a Buy at Stifel
1M ago
EVMN
Evommune’s EVO756 Phase 2b Trial: An Emerging Catalyst in Atopic Dermatitis
PremiumCompany Announcements
Evommune’s EVO756 Phase 2b Trial: An Emerging Catalyst in Atopic Dermatitis
1M ago
EVMN
Six new option listings on April 23rd
PremiumThe Fly
Six new option listings on April 23rd
2M ago
GRO
ALOY
Evommune: Differentiated MRGPRX2 Strategy and Upcoming EVO756 Phase IIb Readout Support Buy Rating
PremiumRatings
Evommune: Differentiated MRGPRX2 Strategy and Upcoming EVO756 Phase IIb Readout Support Buy Rating
2M ago
EVMN
Evommune Spotlights EVO756 as Novel Preventive Migraine Therapy
PremiumCompany Announcements
Evommune Spotlights EVO756 as Novel Preventive Migraine Therapy
2M ago
8K
EVMN
Evommune assumed with an Outperform at Oppenheimer
PremiumThe FlyEvommune assumed with an Outperform at Oppenheimer
2M ago
EVMN
3 Best Stocks to Buy Today, 3/18/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 3/18/2026, According to Top Analysts
3M ago
UAL
EVMN
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
Premium
The Fly
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
3M ago
CF
EXR
Evommune: Buy Rating Backed by 2026 Catalyst Rich Pipeline and Differentiated MRGPRX2 Dermatology Franchise
PremiumRatings
Evommune: Buy Rating Backed by 2026 Catalyst Rich Pipeline and Differentiated MRGPRX2 Dermatology Franchise
3M ago
EVMN
Evommune price target lowered to $50 from $65 at H.C. Wainwright
PremiumThe Fly
Evommune price target lowered to $50 from $65 at H.C. Wainwright
3M ago
EVMN
Evommune initiated with a Buy at Clear Street
PremiumThe Fly
Evommune initiated with a Buy at Clear Street
3M ago
EVMN
Evommune initiated with an Outperform at RBC Capital
PremiumThe Fly
Evommune initiated with an Outperform at RBC Capital
3M ago
EVMN
Evommune Reports Q4 2025 Results and Pipeline Progress
PremiumCompany AnnouncementsEvommune Reports Q4 2025 Results and Pipeline Progress
3M ago
8K
EVMN
Evommune reports Q4 EPS ($1.43), consensus (84c)
Premium
The Fly
Evommune reports Q4 EPS ($1.43), consensus (84c)
3M ago
EVMN
Evommune, Inc.: Lead in MRGPRX2 Modulation and Differentiated EVO756 Profile Support Buy Rating
Premium
Ratings
Evommune, Inc.: Lead in MRGPRX2 Modulation and Differentiated EVO756 Profile Support Buy Rating
3M ago
EVMN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >